Millrose Properties, Inc. Class A Common Stock (MRP)
27.72
-0.18 (-0.65%)
NYSE · Last Trade: Apr 7th, 9:03 PM EDT
Millrose Properties generates income through land option agreements with homebuilders, tying its cash flow to residential development activity. The company's performance is driven by builder demand and the pace of land transactions.
Via The Motley Fool · April 7, 2026

Millrose Properties gives homebuilders efficient land access and offers investors income exposure backed by residential real estate.
Via The Motley Fool · March 4, 2026

Millrose (MRP) Q4 2025 Earnings Call Transcript
Via The Motley Fool · February 26, 2026
Today’s Date: December 22, 2025 Introduction Lennar Corporation (NYSE: LEN), one of the largest homebuilders in the United States, stands at a pivotal crossroads as 2025 draws to a close. Despite a year characterized by a significant strategic spin-off and robust delivery volumes, the company’s recent fourth-quarter earnings report, released on December 16, 2025, has [...]
Via PredictStreet · December 22, 2025
Lennar is a forever holding for me.
Via The Motley Fool · December 29, 2025
After a sharp post-spin rally, one investor’s trim raises a question about how Millrose fits into long-term housing capital strategies.
Via The Motley Fool · December 15, 2025
Millrose’s latest numbers hint at a business model hitting its stride even as one institutional investor steps back.
Via The Motley Fool · December 9, 2025
A newly public real-estate platform is putting up numbers that look far more seasoned than its age.
Via The Motley Fool · December 7, 2025
Via The Motley Fool · October 15, 2025
Millrose Properties (MRP) shows strong technical breakout potential with a 7/10 Technical Rating and perfect 10 Setup Quality. Rising trends, tight consolidation, and clear support levels suggest a bullish move.
Via Chartmill · August 16, 2025
Via Benzinga · May 27, 2025
Via Benzinga · April 14, 2025
Top performers last week: DGNX (108.29%), NEXT (25.07%), CELH (21.60%), SIG (21.08%), NFE (20.63%), MRP (16.61%), ARQT (16.35%), LCID (15.79%), CPRX (15.27%), STNE (14.20%). Are they in your portfolio?
Via Benzinga · March 23, 2025
